Long-term survival of patients diagnosed with non-Hodgkin lymphoma after a previous malignancy

References

• Coiffier B. Rituximab in combination with CHOP improves survival in elderly patients with aggressive non-Hodgkin's lymphoma. Semin Oncol 2002; 29: 18–22
   PubMed Web of Science ®Google Scholar
• Pfreundschuh M, Trumper L, Osterborg A, Pettengell R, Trneny M, Imrie K, et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol 2006; 7: 379–391
   PubMed Web of Science ®Google Scholar
• Sehn L H, Donaldson J, Chhanabhai M, Fitzgerald C, Gill K, Klasa R, et al. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. J Clin Oncol 2005; 23: 5027–5033
   PubMed Web of Science ®Google Scholar
• Besson C, Goubar A, Gabarre J, Rozenbaum W, Pialoux G, Châtelet F P, et al. Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood 2001; 98: 2339–2344
   PubMed Web of Science ®Google Scholar
• Diamond C, Taylor T H, Im T, Miradi M, Anton-Culver H. Improved survival and chemotherapy response among patients with AIDS-related non-Hodgkin's lymphoma receiving highly active antiretroviral therapy. Hematol Oncol 2006; 24: 139–145
   PubMed Web of Science ®Google Scholar
• Hoffmann C, Chow K U, Wolf E, Faetkenheuer G, Stellbrink H J, van Lunzen J, et al. Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus-associated Hodgkin's disease. Br J Haematol 2004; 125: 455–462
   PubMed Web of Science ®Google Scholar
• Pettengell R, Radford J A, Morgenstern G R, Scarffe J H, Harris M, Woll P J, et al. Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma. J Clin Oncol 1996; 14: 586–592
   PubMed Web of Science ®Google Scholar
• Rueffer U, Josting A, Franklin J, May M, Sieber M, Breuer K, et al. Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis. J Clin Oncol 2001; 19: 2026–2032
   PubMed Web of Science ®Google Scholar
• Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Mortality – All COD, Public-Use With State, Total U.S. (1969–2004), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2007. Underlying mortality data provided by NCHS (www.cdc.gov/nchs)
   Google Scholar
• Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) Limited-Use Data (1973–2004), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2007, based on the November 2006 submission
   Google Scholar
• Brenner H, Gefeller O, Hakulinen T. Period analysis for ‘up-to-date’ cancer survival data: theory, empirical evaluation, computational realisation and applications. Eur J Cancer 2004; 40: 326–335
   PubMed Web of Science ®Google Scholar
• Brenner H, Hakulinen T. Up-to-date and precise estimates of cancer patient survival: model-based period analysis. Am J Epidemiol 2006; 164: 689–696
   PubMed Web of Science ®Google Scholar
• Brenner H, Gefeller O. An alternative approach to monitoring cancer patient survival. Cancer 1996; 78: 2004–2010
   PubMed Web of Science ®Google Scholar
• Brenner H, Hakulinen T. Up-to-date long-term survival curves of patients with cancer by period analysis. J Clin Oncol 2002; 20: 826–832
   PubMed Web of Science ®Google Scholar
• Brenner H, Soderman B, Hakulinen T. Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370,000 cancer patients in Finland. Int J Epidemiol 2002; 31: 456–462
   PubMed Web of Science ®Google Scholar
• Ederer F, Axtell L M, Cutler S J. The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr 1961; 6: 101–121
   PubMedGoogle Scholar
• Henson D E, Ries L A. The relative survival rate. Cancer 1995; 76: 1687–1688
   PubMed Web of Science ®Google Scholar
• Ederer F, Heise H. Instructions to IBM 650 programmers in processing survival computations. Methodological Note No. 10. National Cancer Institute, Bethesda, MD 1959
   Google Scholar
• Arias E. United States life tables, 2000. Natl Vit Stat Rep 2002; 51: 1–39
   PubMedGoogle Scholar
• Krishnan B, Morgan G J. Non-Hodgkin lymphoma secondary to cancer chemotherapy. Cancer Epidemiol Biomarkers Prev 2007; 16: 377–380
   PubMed Web of Science ®Google Scholar